Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy.
about
Ionic homeostasis in brain conditioningWindow of opportunity: estrogen as a treatment for ischemic strokeA Comparative Study of Variables Influencing Ischemic Injury in the Longa and Koizumi Methods of Intraluminal Filament Middle Cerebral Artery Occlusion in MiceCocktail treatment, a promising strategy to treat acute cerebral ischemic stroke?Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injuryNeuroprotection and thrombolysis: combination therapy in acute ischaemic strokeStudies of isolated global brain ischaemia: III. Influence of pulsatile flow during cerebral perfusion and its link to consistent full neurological recovery with controlled reperfusion following 30 min of global brain ischaemia.Multimodal MRI of experimental stroke.A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion.Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema.Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies.A modified mini-stroke model with region-directed reperfusion in rat cortex.Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia.Stem cell transplantation in brain tumors: a new field for molecular imaging?Gene inactivation of Na+/H+ exchanger isoform 1 attenuates apoptosis and mitochondrial damage following transient focal cerebral ischemiaRemote ischemic postconditioning confers neuroprotective effects via inhibition of the BID-mediated mitochondrial apoptotic pathwayReduction of cerebral infarct size by dronedarone.Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke.Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion.The effects of soy extract on spatial learning and memory damage induced by global ischemia in ovariectomised rats.Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies.Protective effects of Lycium barbarum polysaccharide on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion.Endovascular treatment of the distal internal carotid artery large aneurysm.Reperfusion promotes mitochondrial dysfunction following focal cerebral ischemia in rats.Expression and purification of TAT-fused carbonic anhydrase III and its effect on C2C12 cell apoptosis induced by hypoxia/reoxygenationMetabolic T1 dynamics and longitudinal relaxation enhancement in vivo at ultrahigh magnetic fields on ischemia.Alternative mitochondrial electron transfer as a novel strategy for neuroprotection.Cardiac function and the proinflammatory cytokine response after recovery from cardiac arrest in swine.Does early postresuscitation stress hyperglycemia affect 72-hour neurologic outcome? Preliminary observations in the Swine model.Arterial spin labeling and dynamic susceptibility contrast CBF MRI in postischemic hyperperfusion, hypercapnia, and after mannitol injectionAttenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery.Subacute Neurological Deterioration with Selective Axonal Injury in Patients with Acute Ischemic Stroke following Reperfusion of Middle Cerebral Artery OcclusionAdvances in stroke therapyCerebral venous infarction: the pathophysiological concept.Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia.Studies of isolated global brain ischaemia: II. Controlled reperfusion provides complete neurologic recovery following 30 min of warm ischaemia - the importance of perfusion pressure.PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System InflammationThe Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.The alternative complement pathway propagates inflammation and injury in murine ischemic strokeProtective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury.
P2860
Q26796249-09103EEE-4BAD-4DFA-8E2E-453C232072ECQ26828794-EFBAE0A1-9E6E-4AF6-9739-F57FB956C3D2Q27323219-4B3F4BC2-8353-42F6-A921-949469A43FDBQ28077232-54B7AB31-F347-4A30-B782-D51E17DBE24AQ28085174-5A9494B9-F2FC-4293-AA44-F8136945A10EQ28199814-63FC6907-4747-4F0C-8F6B-B833300384F0Q30513410-54A45C9D-5734-40D9-9DD1-9FF16D2848C7Q30712185-885D5F7F-84A4-4B1C-B3C6-8AB6F9DB0524Q30838086-4FCAFC2F-C9B3-4096-AAD8-079833427736Q30884854-D881C5F0-5D54-4C51-99D9-1804CA9CBC2EQ31086283-9F530F62-5ECF-4892-83FE-4F4AAB93F8E5Q33309771-B23303B3-CA50-4F8C-B6E1-6833C4229CD0Q33456516-0BB4960D-1E21-46C3-B47D-38CA134C81E4Q33622514-47B2696E-4B91-49C3-A70A-83E8239E68CBQ33643893-6BF90ACA-D522-4ACD-B549-C5339D4B4BF3Q33828097-634BE11F-3EC1-491B-AACE-A8C321742238Q34007040-24958552-E72A-4572-9505-D35C03D54BF4Q34024724-BA8758C7-AFDD-4C5E-B9BC-2F8BD781EE4EQ34126249-99B7AE4F-D8C5-4B23-A5F3-657778BBD055Q34178098-EB545CF1-5458-4588-B91B-92C6B7C6F8DBQ34203215-DDD2BAF8-2CAD-46F7-A84C-6DDFD738BE24Q34259416-F44388BA-12E8-491B-9096-3D1F2EE7E256Q34381693-3A65DE2C-606E-4ADE-8076-59E9BEFE7173Q34431361-AE0660AB-99BC-42F6-93C4-E5975F6F3C6BQ34440733-7C92B702-0138-457E-BF5D-C706B5D00790Q34727486-71CC4750-B50D-42D3-91F8-9F43B9DF3629Q34963810-3445AE1A-AED3-42BE-BD14-96E7334D063CQ34987232-316E57C6-AC19-43A2-9985-90B3991104BBQ35009572-4178C53D-90A2-4150-A956-C4DAA1BE67DEQ35088178-1CB12D8F-9866-4462-9DD0-2DC6C0FE2CBDQ35120831-199C7BD4-ED61-4FC1-B3BB-524B2C858A04Q35545642-FB62BD28-4796-4061-823F-75C8E1C9CC8BQ35632748-331352BA-85D0-48EC-AC05-D9B619A87363Q35845321-89922ADE-F066-43C2-A135-A26361F9F9D2Q35866882-6890E8EC-648C-4D3F-88D9-E8772CB55C30Q35892787-61CA6FB6-348E-4A28-989C-1AF63B55AA68Q36109112-633D6F31-7E6F-4131-9E8B-74B02C5797C9Q36276992-EB246C13-C982-4D7E-B675-86585E8FCF31Q36339354-4697B820-5D26-429B-A4D8-FFC532FB3613Q36374492-41129F3F-7554-406E-A49F-28352217FC45
P2860
Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cerebral ischemia and reperfus ...... a basis for clinical therapy.
@ast
Cerebral ischemia and reperfus ...... a basis for clinical therapy.
@en
type
label
Cerebral ischemia and reperfus ...... a basis for clinical therapy.
@ast
Cerebral ischemia and reperfus ...... a basis for clinical therapy.
@en
prefLabel
Cerebral ischemia and reperfus ...... a basis for clinical therapy.
@ast
Cerebral ischemia and reperfus ...... a basis for clinical therapy.
@en
P1476
Cerebral ischemia and reperfus ...... a basis for clinical therapy.
@en
P2093
Bernhard Schaller
Rudolf Graf
P304
P356
10.1097/00004647-200404000-00001
P577
2004-04-01T00:00:00Z
P5875
P6179
1029523017